Shelton Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Shelton Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,555	Closed	-$587K	–	860
2021 Q2	$587K	Hold	3,555	–	–	0.02%	338
2021 Q1	$545K	Sell	3,555 -130	-4%	-$17.7K	0.02%	364
2020 Q4	$462K	Hold	3,685	–	–	0.02%	366
2020 Q3	$374K	Hold	3,685	–	–	0.02%	484
2020 Q2	$359K	Sell	3,685 -333	-8%	-$31K	0.02%	391
2020 Q1	$334K	Buy	4,018 +393	+11%	+$38.3K	0.02%	368
2019 Q4	$403K	Hold	3,625	–	–	0.02%	413
2019 Q3	$360K	Hold	3,625	–	–	0.02%	453
2019 Q2	$359K	Buy	3,625 +3,225	+806%	+$308K	0.02%	457
2019 Q1	$3.63K	Sell	400 -3,225	-89%	-$337K	0.01%	667
2018 Q4	$333K	Hold	3,625	–	–	0.02%	433
2018 Q3	$399K	Buy	+3,625	New	+$377K	0.02%	442

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Shelton Capital Management's PRAH Position: Q3 2021 in Review

Shelton Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 3,555 shares — an estimated $587K sold.

Shelton Capital Management first reported a position in PRAH in Q3 2018 and held it in 12 quarters. The position peaked at $587K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Shelton Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Shelton Capital Management sold 3,555 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $587K.
Shelton Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 12 quarters.
Shelton Capital Management's PRA Health Sciences, Inc. position peaked at $587K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Shelton Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.